• Fund Type: Unit Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

AXA Framlington Biotech Fund

+ Add to Watchlist

FRABIOZ:LN

228.90 GBp 2.50 1.08%

As of 00:59:30 ET on 10/01/2014.

Snapshot for AXA Framlington Biotech Fund (FRABIOZ)

Year To Date: +23.58% 3-Month: +12.39% 3-Year: - 52-Week Range: 162.99 - 232.50
1-Month: +1.01% 1-Year: +31.93% 5-Year: - Beta vs NBI: 0.95

Mutual Fund Chart for FRABIOZ

No chart data available.
  • FRABIOZ:LN 228.90
  • 1M
  • 1Y
Interactive FRABIOZ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FRABIOZ

AXA Framlington Biotech Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to provide long-term capital appreciation The Fund will invest principally in equity securities of companies in the biotechnology, genomic and medical research industries worldwide.

Inception Date: 04-16-2012 Telephone: 44-207-374-4100
Managers: LINDEN THOMSON / GEMMA GAME
Web Site: www.axa-framlington.com

Fundamentals for FRABIOZ

NAV (on 2014-10-01) 228.90
Assets (M) (on 2014-09-29) 380.84
Fund Leveraged N
Minimum Investment 100,000.00
Minimum Subsequent Investment 5,000.00

Dividends for FRABIOZ

Dividend Type Omitted
Dividend Frequency Semi-Anl
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for FRABIOZ

Front Load 0.00
Back Load -
Current Mgmt Fee 0.75
Redemption Fee -
12b1 Fee -
Expense Ratio -

Top Fund Holdings for FRABIOZ

Filing Date: 08/29/2014
Name Position Value % of Total
Gilead Sciences Inc 542,902 35,211,400 9.800%
Celgene Corp 602,009 34,492,800 9.600%
Amgen Inc 342,008 28,744,000 8.000%
Biogen Idec Inc 102,483 21,198,700 5.900%
Vertex Pharmaceuticals Inc 331,141 18,683,600 5.200%
Illumina Inc 149,497 16,168,500 4.500%
Alexion Pharmaceuticals Inc 151,350 15,449,900 4.300%
BioMarin Pharmaceutical Inc 284,461 12,216,200 3.400%
Salix Pharmaceuticals Ltd 119,839 11,497,600 3.200%
Incyte Corp 329,814 10,779,000 3.000%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil